Global autoinjectors market is projected to grow at an annualized rate of over 10% / till 2030

Autoinjectors have become an important part of modern healthcare, having demonstrated the potential to address a number of parenteral drug delivery related adverse events, and improve medication adherence among patients

Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Autoinjectors Market (3rd Edition), 2020-2030.”

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of autoinjectors over the next decade. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:

• A detailed assessment of the current market landscape of developers engaged in the development and / or manufacturing autoinjectors.
• A detailed assessment of current landscape of companies that are developing drugs in combination with autoinjectors.
• A competitiveness analysis of various disposable and reusable autoinjectors.
• A detailed brand positioning analysis of leading industry players highlighting the current perceptions regarding their proprietary brands.
• A list of marketed drugs / therapies and pipeline candidates that are likely to be developed in combination with autoinjectors in the near future.
• A list of key opinion leaders (KOLs) within this domain with significant contributions in clinical trials and filing patent applications.
• Detailed case studies on the most commonly targeted indications of the approved autoinjector products.
• A case study on the role of CMOs offering services for drug delivery devices.
• A SWOT analysis capturing the key parameters and trends that are likely to influence the future of autoinjectors market.
• Elaborate profiles of autoinjector manufacturers that have more than three devices in their respective product portfolios.
• A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
• Over time, more than 4,600 patents have been filed / granted related to autoinjectors and affiliated products; most of the new intellectual property is related to additional features, such as safety locks and device connectivity
• Eminent scientists from renowned organizations and academic institutions across the world have made valuable contributions to this field, in terms of leading clinical research efforts and developing novel technologies
• Several autoinjector developers have established strong brand positions in different geographies; the focus, in the near term, is likely to be on further enhancing device features for better disease management and improved patient compliance
• An evaluation of 200+ marketed and pipeline products revealed that a variety of drugs / product candidates are likely to be considered for administration via autoinjectors in the near future
• Case Study: Owing to the complexities associated with the manufacturing and assembly of autoinjector drug delivery systems, industry players are known to frequently engage the services of contract service providers

• Usability
• Disposable
• Reusable
• Route of Administration
• Subcutaneous
• Intramuscular
• Type of Molecule
• Monoclonal Antibody
• Peptide
• Protein
• Small Molecule
• Therapeutic Indication
• Anaphylaxis
• Asthma
• Multiple Sclerosis
• Rheumatoid Arthritis
• Migraine
• Diabetes
• Other Indications
• Key Geographies
• North America
• Europe
• Asia-Pacific
• Rest of the World

The research, analysis and insights presented in this report are backed by a deep understanding of key insights gathered from both secondary and primary research. The opinions and insights presented in the report were influenced by discussions held with several players in this industry. The study includes detailed transcripts of discussions held with the following individuals:

• David Daily (CEO and Co-founder, DALI Medical Devices)
• Dennis Lee (Senior Program Officer in CMC, Bill & Melinda Gates Foundation)
• Douglas Marenzi (Managing Director, PHC Injection Technologies)
• Tsachi Shaked (Senior Marketing and BD Director, Injectable Drug Delivery Devices, Elcam Medical)
• Jesse Fourt (Design Director, IDEO)

Key companies covered in the report

• Antares Pharma
• Consort Medical (Previously Bespak)
• DALI Medical Devices
• Elcam Medical (E3D Elcam Drug Delivery Devices)
• Jiangsu Delfu Medical Devices
• Oval Medical Technologies
• Owen Mumford
• SHL Group
• Union Medico®
• Ypsomed

For more information please click on the following

https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html

Other Recent Offerings

1. Prefilled Syringes Market (5th Edition), 2019-2030
2. Novel Vaccine Delivery Devices Market, 2019-2030
3. Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]